Longitudinal study about the impact of treatment with tumor necrosis factor (TNF) inhibitors on tuberculin skin test (TST) reaction in patients with rheumatoid arthritis (RA).

Longitudinal study about the impact of treatment with tumor necrosis factor (TNF) inhibitors on tuberculin skin test (TST) reaction in patients with rheumatoid arthritis (RA). - Longitudinal study about the impact of monoclonal antibody to TNF treatment on TST reaction in patients with RA in Jichi medical university.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021048

Enrollment

100

Registered

2016-02-16

Start date

2008-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis (RA)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients with RA who had been treated with infliximab or etanercept for more than a year.

Exclusion criteria

Exclusion criteria: Patients who are pregnant, breast-feed, and desire to be pregnant.

Design outcomes

Primary

Measure	Time frame
TST in patients with RA before and one or more years after the introduction of the treatment with TNF inhibitors.	—

Countries

Japan

Contacts

Public ContactKatsuya Nagatani

Jichi Medical University Division of Rheumatology and Clinical Immunology, Department of Medicine

knagatani@jichi.ac.jp0285-58-7358

Outcome results